QPharma Names Badal Shah as Managing Director, KOL and Targeting
Thought Leader Utilization: Refining Strategies and Tactics for Optimal KOL Engagement - Research and Markets
QPharma Acquires MedStart Connect Sample Kiosk Program
Coal ETFs carry above-average risk but offer compelling reward potential right now.
Genomic Vision: High Attendance at the 1st US Satellite Symposium on Molecular Combing
Rob Eshman, Long-Time Jewish Journal Editor-in-Chief and Publisher, to Leave Post for Writing Projects